Perspective Therapeutics, Inc.CATXNYSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank57
3Y CAGR-35.6%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-35.6%/yr
vs +239.8%/yr prior
Acceleration
-275.4pp
Decelerating
Percentile
P57
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 13.60% |
| 2024 | 26.34% |
| 2023 | 48.19% |
| 2022 | 50.81% |
| 2021 | 32.17% |
| 2020 | -5.51% |
| 2019 | 10.16% |
| 2018 | 0.38% |
| 2017 | 9.59% |
| 2016 | 21.18% |